| Tania Lopez, CNM | |
|
855 Montgomery St, Fort Worth, TX 76107-2553 | |
| (817) 735-2363 | |
| (817) 702-6561 |
| Full Name | Tania Lopez |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 855 Montgomery St, Fort Worth, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861408775 | NPI | - | NPPES |
| 177150301 | Medicaid | TX | |
| 8N9742 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 597529 (Texas) | Primary |
| Entity Name | University Of North Texas Health Science Center At Fort Worth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376645564 PECOS PAC ID: 6103717350 Enrollment ID: O20040324001382 |
News Archive
According to the latest research the newer antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs) only slightly increase the risk of birth defects in pregnancy.
True to its commitment to bring world-class care to patients in Brooklyn, the NYU Langone Health System is building a sophisticated, technologically advanced and clinically integrated health network in the borough.
The skeleton is constantly being remodelled by the breakdown of old bone by cells called osteoclasts and the formation of new bone by cells called osteoblasts. This coordinated activity is essential for maintaining healthy bone. However, excessive osteoclast activity leads to bone destruction in skeletal diseases such as osteoporosis, rheumatoid arthritis and cancer metastases in bone. A family of signaling enzymes known as phosphatidylinositol 3-kinases control diverse cell functions but, up until now, little was known about the function of specific PI3K isoforms in osteoclasts.
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced at its 2010 Annual Meeting of Stockholders that it received the approval of its stockholders to increase the number of authorized shares of the Company from 155 million to 205 million. In addition, stockholders re-elected Neoprobe President and CEO David C. Bupp, and elected for the first time, Brendan A. Ford and Eric K. Rowinsky, M.D. as Directors of the Company for terms ending at the 2013 Annual Meeting. Stockholders also approved the appointment of BDO Seidman, LLP to act as the Company's independent registered public accounting firm for 2010.
› Verified 4 days ago
| Entity Name | Pediatrix Medical Group Of Texas Billing Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649377359 PECOS PAC ID: 0042283921 Enrollment ID: O20110907001264 |
News Archive
According to the latest research the newer antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs) only slightly increase the risk of birth defects in pregnancy.
True to its commitment to bring world-class care to patients in Brooklyn, the NYU Langone Health System is building a sophisticated, technologically advanced and clinically integrated health network in the borough.
The skeleton is constantly being remodelled by the breakdown of old bone by cells called osteoclasts and the formation of new bone by cells called osteoblasts. This coordinated activity is essential for maintaining healthy bone. However, excessive osteoclast activity leads to bone destruction in skeletal diseases such as osteoporosis, rheumatoid arthritis and cancer metastases in bone. A family of signaling enzymes known as phosphatidylinositol 3-kinases control diverse cell functions but, up until now, little was known about the function of specific PI3K isoforms in osteoclasts.
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced at its 2010 Annual Meeting of Stockholders that it received the approval of its stockholders to increase the number of authorized shares of the Company from 155 million to 205 million. In addition, stockholders re-elected Neoprobe President and CEO David C. Bupp, and elected for the first time, Brendan A. Ford and Eric K. Rowinsky, M.D. as Directors of the Company for terms ending at the 2013 Annual Meeting. Stockholders also approved the appointment of BDO Seidman, LLP to act as the Company's independent registered public accounting firm for 2010.
› Verified 4 days ago
| Entity Name | Acclaim Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
According to the latest research the newer antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs) only slightly increase the risk of birth defects in pregnancy.
True to its commitment to bring world-class care to patients in Brooklyn, the NYU Langone Health System is building a sophisticated, technologically advanced and clinically integrated health network in the borough.
The skeleton is constantly being remodelled by the breakdown of old bone by cells called osteoclasts and the formation of new bone by cells called osteoblasts. This coordinated activity is essential for maintaining healthy bone. However, excessive osteoclast activity leads to bone destruction in skeletal diseases such as osteoporosis, rheumatoid arthritis and cancer metastases in bone. A family of signaling enzymes known as phosphatidylinositol 3-kinases control diverse cell functions but, up until now, little was known about the function of specific PI3K isoforms in osteoclasts.
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced at its 2010 Annual Meeting of Stockholders that it received the approval of its stockholders to increase the number of authorized shares of the Company from 155 million to 205 million. In addition, stockholders re-elected Neoprobe President and CEO David C. Bupp, and elected for the first time, Brendan A. Ford and Eric K. Rowinsky, M.D. as Directors of the Company for terms ending at the 2013 Annual Meeting. Stockholders also approved the appointment of BDO Seidman, LLP to act as the Company's independent registered public accounting firm for 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tania Lopez, CNM 855 Montgomery St, Fort Worth, TX 76107-2553 Ph: (817) 735-2363 | Tania Lopez, CNM 855 Montgomery St, Fort Worth, TX 76107-2553 Ph: (817) 735-2363 |
News Archive
According to the latest research the newer antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs) only slightly increase the risk of birth defects in pregnancy.
True to its commitment to bring world-class care to patients in Brooklyn, the NYU Langone Health System is building a sophisticated, technologically advanced and clinically integrated health network in the borough.
The skeleton is constantly being remodelled by the breakdown of old bone by cells called osteoclasts and the formation of new bone by cells called osteoblasts. This coordinated activity is essential for maintaining healthy bone. However, excessive osteoclast activity leads to bone destruction in skeletal diseases such as osteoporosis, rheumatoid arthritis and cancer metastases in bone. A family of signaling enzymes known as phosphatidylinositol 3-kinases control diverse cell functions but, up until now, little was known about the function of specific PI3K isoforms in osteoclasts.
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced at its 2010 Annual Meeting of Stockholders that it received the approval of its stockholders to increase the number of authorized shares of the Company from 155 million to 205 million. In addition, stockholders re-elected Neoprobe President and CEO David C. Bupp, and elected for the first time, Brendan A. Ford and Eric K. Rowinsky, M.D. as Directors of the Company for terms ending at the 2013 Annual Meeting. Stockholders also approved the appointment of BDO Seidman, LLP to act as the Company's independent registered public accounting firm for 2010.
› Verified 4 days ago
Crystal Rene Rose, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7016 Bryant Irvin Rd Ste 100, Fort Worth, TX 76132 Phone: 817-377-8820 Fax: 817-377-8450 | |
Candis M Hicks, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 320, Fort Worth, TX 76104 Phone: 817-250-7360 | |
Ashlyn E Sconyers, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 10345 Alta Vista Rd, Fort Worth, TX 76244 Phone: 817-562-2828 | |
Shannon Riley Dasilva, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4801 Sleepy Ridge Cir, Fort Worth, TX 76133 Phone: 817-727-2066 | |
Katrina Karn, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 622 Hemphill St, Fort Worth, TX 76104 Phone: 817-878-2737 | |
Ms. Sarah Katherine Morrow, CRNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 340, Fort Worth, TX 76104 Phone: 817-702-9000 Fax: 817-882-8653 | |
Katherine Lacey Hopkins, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 320, Fort Worth, TX 76104 Phone: 817-250-7360 |